Patents Assigned to TOLEROGENIXX GMBH
  • MIC therapy for specific immunosuppression in transplantation
    Patent number: 11554139
    Abstract: The present invention relates to pharmaceutical compositions with isolated and treated whole blood cells or Peripheral Blood Mononuclear Cells (PBMCs) as well as such pharmaceutical compositions for use in the prevention and/or treatment of organ or cell graft rejection in a human graft recipient.
    Type: Grant
    Filed: May 17, 2019
    Date of Patent: January 17, 2023
    Assignees: TOLEROGENIXX GMBH, UNIVERSITÄT HEIDELBERG
    Inventors: Christian Morath, Anita Schmitt, Matthias Schaier, Gerhard Opelz, Peter Terness, Christian Kleist, Volker Daniel, Caner Süsal, Michael Schmitt, Martin Zeier